BridgeBio Oncology Therapeutics BBOT Ratios (2023-2026)

NASDAQ BBOT
$3.92 +0.11 (+2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BridgeBio Oncology Therapeutics Quarterly Ratios

Periods 11 quarters
Latest Jun 2026

BridgeBio Oncology Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 93.93M188.70M191.10M178.32M179.99M196.53M341.09M466.59M433.01M397.18M
Equity AverageEquity Avg. -122.25M-136.15M-151.32M-168.92M-189.34M-213.88M109.48M428.90M391.69M347.70M
Invested CapitalInvested Cap. -115.57M-178.15M-199.95M-227.63M447.39M411.63M373.00M
Leverage & Solvency
Debt Ratio 0.210.000.000.000.000.000.00
Valuation
Price to EarningsP/E 29.2477.96140.44
Price to BookP/B 1.621.901.501.89
Enterprise Value 367.93M422.27M431.84M66.59M467.69M661.85M254.11M355.58M306.06M384.77M
Market Capitalization 369.78M424.09M433.63M222.22M468.66M662.51M722.40M781.04M558.33M610.48M
Return Ratios
Return on Capital Employed [ROCE]ROCE -26.31%-36.40%-48.88%-40.70%-33.79%-43.33%-57.58%
Return on Assets [ROA]ROA -18.68%-30.89%-43.71%-34.59%-30.38%-38.52%-50.09%
Return on Equity [ROE]ROE -107.76%-33.05%-42.58%-57.22%

BridgeBio Oncology Therapeutics Ratios API

Pull BridgeBio Oncology Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BBOT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY